MMYT vs. MLTX

Last updated Apr 2, 2026

Compare and contrast key facts about MakeMyTrip Limited (MMYT) and MoonLake Immunotherapeutics (MLTX).

Performance

MMYT vs. MLTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MakeMyTrip Limited (MMYT) and MoonLake Immunotherapeutics (MLTX). The values are adjusted to include any dividend payments, if applicable.

MMYT vs. MLTX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
MMYT MakeMyTrip Limited	-53.87%	-26.86%	139.00%	70.40%	-0.51%	-6.16%	53.88%
MLTX MoonLake Immunotherapeutics	25.34%	-75.66%	-10.33%	475.14%	6.17%	-13.02%	8.39%

Fundamentals

Market Cap MMYT : $3.76B MLTX : $1.06B
EPS MMYT : $0.54 MLTX : -$3.60
Total Revenue (TTM) MMYT : $1.04B MLTX : $0.00
Gross Profit (TTM) MMYT : $722.83M MLTX : -$1.49M
EBITDA (TTM) MMYT : $187.83M MLTX : -$219.85M

Returns By Period

In the year-to-date period, MMYT achieves a -53.87% return, which is significantly lower than MLTX's 25.34% return.

MMYT

• 1D: 1.58%
• 1M: -32.28%
• YTD: -53.87%
• 6M: -58.98%
• 1Y: -61.79%
• 3Y*: 15.68%
• 5Y*: 3.38%
• 10Y*: 7.72%

MLTX

• 1D: -11.37%
• 1M: -6.56%
• YTD: 25.34%
• 6M: 133.99%
• 1Y: -54.55%
• 3Y*: -8.25%
• 5Y*: 9.99%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

MMYT vs. MLTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MMYT

MMYT Risk / Return Rank: 3
MMYT Sharpe Ratio Rank: 1
MMYT Sortino Ratio Rank: 2
MMYT Omega Ratio Rank: 2
MMYT Calmar Ratio Rank: 7
MMYT Martin Ratio Rank: 1

MLTX

MLTX Risk / Return Rank: 36
MLTX Sharpe Ratio Rank: 20
MLTX Sortino Ratio Rank: 52
MLTX Omega Ratio Rank: 70
MLTX Calmar Ratio Rank: 19
MLTX Martin Ratio Rank: 22

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MMYT vs. MLTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MakeMyTrip Limited (MMYT) and MoonLake Immunotherapeutics (MLTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MMYT	MLTX	Difference
Sharpe ratio Return per unit of total volatility	-1.26	-0.47	-0.79
Sortino ratio Return per unit of downside risk	-2.09	0.90	-2.99
Omega ratio Gain probability vs. loss probability	0.73	1.22	-0.49
Calmar ratio Return relative to maximum drawdown	-0.90	-0.64	-0.26
Martin ratio Return relative to average drawdown	-2.04	-1.04	-1.00
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MMYT vs. MLTX - Sharpe Ratio Comparison

The current MMYT Sharpe Ratio is -1.26, which is lower than the MLTX Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of MMYT and MLTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	MMYT	MLTX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.26	-0.47	-0.79
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.07	0.11	-0.04
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.15	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.04	0.10	-0.06

Correlation

The correlation between MMYT and MLTX is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

MMYT vs. MLTX - Dividend Comparison

Neither MMYT nor MLTX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

MMYT vs. MLTX - Drawdown Comparison

The maximum MMYT drawdown since its inception was -73.45%, smaller than the maximum MLTX drawdown of -90.22%. Use the drawdown chart below to compare losses from any high point for MMYT and MLTX.

Drawdown Indicators

	MMYT	MLTX	Difference
Max Drawdown Largest peak-to-trough decline	-73.45%	-90.22%	+16.77%
Max Drawdown (1Y) Largest decline over 1 year	-67.94%	-89.93%	+21.99%
Max Drawdown (5Y) Largest decline over 5 years	-69.87%	-90.22%	+20.35%
Max Drawdown (10Y) Largest decline over 10 years	-73.45%	—	—
Current Drawdown Current decline from peak	-68.55%	-74.13%	+5.58%
Average Drawdown Average peak-to-trough decline	-36.06%	-27.79%	-8.27%
Ulcer Index Depth and duration of drawdowns from previous peaks	30.12%	55.51%	-25.39%

Volatility

MMYT vs. MLTX - Volatility Comparison

The current volatility for MakeMyTrip Limited (MMYT) is 17.56%, while MoonLake Immunotherapeutics (MLTX) has a volatility of 20.19%. This indicates that MMYT experiences smaller price fluctuations and is considered to be less risky than MLTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MMYT	MLTX	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.56%	20.19%	-2.63%
Volatility (6M) Calculated over the trailing 6-month period	36.54%	57.60%	-21.06%
Volatility (1Y) Calculated over the trailing 1-year period	49.04%	116.94%	-67.90%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	48.57%	90.46%	-41.89%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	52.99%	87.19%	-34.20%

Financials